BioXcel Therapeutics (BTAI) Earnings Report - Discounting Cash Flows
BioXcel Therapeutics, Inc.
BTAI (NASDAQ)

* (except for per share items) of USD
Period Ending: 2025
08-04
2025
05-07
2025
03-10
2024
11-14
2024
08-06
2024
05-09
2024
03-12
2023
11-14
2023
08-14
2023
05-08
2023
03-09
2022
11-10
2022
08-09
2022
05-09
2022
03-10
2021
11-10
2021
08-10
2021
05-10
2021
03-11
2020
11-12
2020
08-14
2020
05-12
2020
03-09
2019
11-14
2019
08-06
2019
05-07
2019
03-07
2018
11-09
2018
08-08
2018
05-14
2017
12-31
2017
09-30
2017
06-30
2017
03-31
Actual EPS - - - - -0.21 -0.87 -0.76 -1.72 -1.83 -1.84 -1.95 -1.49 -1.35 -1.12 -0.93 -0.96 -1.11 -1.08 -0.87 -1.07 -1.06 -0.79 -0.45 -0.57 -0.54 -0.46 -0.47 -0.31 -0.19 -0.37 -0.22 -0.06 -0.04 -0.03
Estimated EPS - - - -0.54 -0.76 -0.68 -0.98 -1.29 -1.72 -1.56 -1.49 -1.34 -1.20 -1.21 -1.18 -1.08 -1.03 -0.89 -0.87 -0.80 -0.74 -0.55 -0.67 -0.59 -0.52 -0.48 -0.34 -0.26 -0.35 -0.25 - - - -
Actual Revenue - - - - 1.10 0.58 0.38 0.34 0.46 0.21 0.24 0.14 - - - - - - 0.00 0.00 - - - - - - - - - - - - - -
Estimated Revenue - - - 1.31 0.93 0.45 0.71 0.73 0.45 0.50 1.25 - - - - - - 0.01 - - - - 10.9 - - - 4.58 - - - - - - -
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us